Yu Wang

Dr. Yu Wang


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
HLHanli Li
Hanli Li
ZDZhong Dong
Zhong Dong
YYYujing Yang
Yujing Yang
QSQibing Sun
Qibing Sun
FLFengqing Lu
Fengqing Lu
YWYu Wang
Yu Wang
Objective: Inflammation resolution is mediated by specialized pro-resolving lipid mediators (SPMs). It’s of high interest to understand the alterations of SPMs in chronic epilepsy. Methods: Sixty-five patients with chronic epilepsy, 43 healthy controls and 43 patients with non-inflammatory neurological disorders were enrolled in this study. Plasma and cerebrospinal fluid (CSF) levels of SPMs were measured using liquid chromatography-tandem mass spectrometry (LC-MS-MS). Moreover, Resolvin D1 (RvD1) and resolvin E1 (RvE1), as well as pro-inflammatory factors were analyzed by enzyme-linked immunosorbent assay (ELISA). Results: LC-MS-MS found several lipid mediators were altered, especially plasma (P = 0.014) and CSF (P = 0.010) RvE1 levels were decreased in patients with chronic epilepsy. Furthermore, ELISA results showed that in plasma and CSF, RvD1 and RvE1 levels were both lower in patients with chronic epilepsy, while pro-inflammatory factors were higher than in controls. Moreover, plasma RvE1 level was independently negatively associated with the National Hospital Seizure Severity Scale scores (&Bgr; = − 0.00636, P < 0.001). While plasma RvD1 level was correlated with Mini-Mental State Examination scores (R = 0.284, P = 0.022). Conclusion: This study demonstrated decreased levels of RvD1 and RvE1 both in plasma and CSF in patients with chronic epilepsy, suggesting impaired resolution of inflammation in chronic epilepsy. Targeting RvD1 and RvE1 may be a novel direction worthy of further research in the treatment of chronic epilepsy.

28 January 2026 in Advanced Science
Verified
Journal Article
Open access
QWQi Wang
Qi Wang
TQTingting Qu
Tingting Qu
QSQibing Sun
Qibing Sun
RLRan Li
Ran Li
JDJunfei Dong
Junfei Dong
YWYu Wang
Yu Wang
Neuroinflammation is a critical driver of epileptogenesis and cognitive dysfunction in epilepsy; however, targeted anti‐inflammatory therapies remain limited. In this study, we demonstrate that microglial GPR35 orchestrates neuroinflammatory epileptic networks through platelet‐derived growth factor A (PDGFA)‐dependent signaling. Single‐nucleus RNA sequencing of patients with temporal lobe epilepsy (TLE) and pharmacological models reveals selective GPR35 upregulation in disease‐associated microglia. GPR35 deficiency exacerbates seizure susceptibility and cognitive deficits. We further demonstrate that GPR35 activation mitigates seizures, suppresses hippocampal neuroinflammation, and alleviates cognitive deficits. Mechanistically, kynurenic acid–activated GPR35 specifically interacts with PDGFA domain 2 via defined binding motifs, thereby suppressing PDGFA degradation through the ubiquitin–proteasome pathway. This cascade triggers PI3K–AKT signaling and subsequently inhibits pro‐inflammatory responses. Conversely, GPR35 deficiency disrupts this pathway of neuroinflammation, and hyperexcitability. PDGFA overexpression phenocopies GPR35 activation, attenuating inflammation and epileptogenesis. These findings establish GPR35 as a critical modulator of epileptic networks via PDGFA‐dependent anti‐inflammatory signaling, bridging neuroimmune crosstalk with the pathophysiology of epilepsy. Our study identifies GPR35 as a druggable target capable of disrupting the vicious cycle of inflammation and hyperexcitability in epilepsy, offering a dual therapeutic strategy to alleviate seizures and cognitive comorbidities.

8 September 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
CYChanghong Yuan
Changhong Yuan
YZYingchun Zhu
Yingchun Zhu
YWYu Wang
Yu Wang
LZLu Zhang
Lu Zhang
Objective: To investigate whether right-to-left shunt (RLS) associated with patent foramen ovale (PFO) is associated with altered cerebrovascular reactivity (CVR) in migraine patients with aura. Methods: This cross-sectional observational study enrolled migraine patients with aura who attended the outpatient clinic of Anhui No. 2 Provincial People's Hospital between December 2022 and September 2025. All patients underwent contrast-enhanced transcranial Doppler (c-TCD) examination, confirmed by contrast transthoracic echocardiography (c-TTE), to detect RLS and determine PFO status. PFO-negative patients served as the internal control group. RLS was graded (0–3) based on the number of microembolic signals (MES), and patients were further classified as having either latent RLS (microbubbles appearing only after Valsalva maneuver) or persistent RLS (microbubbles appearing at rest). Cerebrovascular reactivity was indirectly assessed by measuring the breath-holding index (BHI) via transcranial Doppler. BHI differences were compared between PFO-positive (+) and PFO-negative (–) groups, between latent and persistent PFO groups, and across different RLS grade groups. Results: Compared with the PFO (–) group, the PFO (+) group exhibited significantly reduced BHI values in the bilateral middle cerebral arteries (MCAs) and bilateral posterior cerebral arteries (PCAs; all P < 0.05). The reduction in BHI became more pronounced with increasing RLS severity grade, showing a significant monotonic trend (Spearman's ρ ranging from −0.401 to −0.466, all P < 0.001). Furthermore, migraine patients with aura who had persistent PFO demonstrated a greater decrease in BHI than those with latent PFO compared with the PFO (–) group ( P < 0.05). Conclusion: RLS associated with PFO is associated with reduced CVR in migraine patients with aura, with more pronounced reductions in cases of large shunts and persistent shunt types.

22 May 2026 in Neurological Sciences
Verified
Journal Article
Closed access
TQTingting Qu
Tingting Qu
YWYiran Wu
Yiran Wu
JLJianxiang Lei
Jianxiang Lei
JDJunfei Dong
Junfei Dong
QWQi Wang
Qi Wang
YWYu Wang
Yu Wang

5 November 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
XLXiaomin Liu
Xiaomin Liu
XZXiya Zhao
Xiya Zhao
YCYinhe Chen
Yinhe Chen
FGFei Gao
Fei Gao
KWKai Wang
Kai Wang
YWYu Wang
Yu Wang
Background: Persistent postural-perceptual dizziness (PPPD) is associated with altered multisensory processing, but its hemispheric functional organization remains poorly understood. We investigated hemispheric functional lateralization and interhemispheric cooperation in PPPD and explored their associations with clinical symptoms and neurotransmitter density maps. Methods: A total of 47 patients with PPPD and 52 healthy controls (HCs) underwent resting-state functional magnetic resonance imaging. Whole-brain maps of the autonomy index (AI) and connectivity between functionally homotopic voxels (CFH) were generated. Between-group differences were assessed using permutation-based analyses adjusted for age, sex, and mean framewise displacement (FD). Associations with clinical measures and spatial correspondence with 13 neurotransmitter density maps were also examined. Results: The PPPD and HC groups did not differ significantly in age, sex, or educational level (all p > 0.05). Patients with PPPD had lower MoCA-BJ scores and higher HAMA-14, HAMD-24, PSQI, and DHI scores than HCs, whereas MMSE scores did not differ significantly. No between-group differences in AI survived family-wise error (FWE) correction. By contrast, in the primary analysis, patients with PPPD showed significantly reduced CFH in the right calcarine cortex, right cuneus, left inferior and middle occipital gyri, left inferior parietal lobule, and right middle temporal gyrus. However, no CFH clusters survived cluster-level FWE correction after separately adjusting for HAMA-14, HAMD-24, or PSQI scores. After adjustment for age, sex, and mean FD, CFH in the right calcarine cortex and left inferior parietal lobule showed negative associations with DHI total and DHI-E scores, respectively (Shepherd’s π = −0.363 and −0.452), but neither association remained significant after false discovery rate (FDR) correction. The CFH group-difference map showed nominal positive spatial correlations with the D 2 R and VACh T density maps, but these associations were not significant after FDR correction. Conclusion: In primary analysis, PPPD patients exhibited reduced interhemispheric functional cooperation in visual, visuospatial and multisensory regions, while no AI differences survived FWE correction. However, these CFH findings were sensitive to adjustment for affective symptoms and sleep quality; the relative contributions of PPPD, affective symptoms and sleep disturbance remain uncertain. Clinical and neurotransmitter density-map associations did not survive FDR correction and are exploratory.